Author/Authors :
A. P. Owens، نويسنده , , Richard T. Harrison، نويسنده , , J. D. Moseley، نويسنده , , C. J. Swain، نويسنده , , S. Sadowski، نويسنده , , M. A. Cascieri، نويسنده ,
Abstract :
Heterocyclic replacements for the carboxamido group of the previously disclosed phenylglycinol-based human NK1 (hNK1) receptor antagonists have been investigated, ultimately leading to acyclic compounds with sub-nanomolar affinity for the hNK1 receptor.
